Abstract
Insulin resistance is an important component of the metabolic syndrome associated with obesity. Early-stage insulin-resistance and related mild glucose intolerance may be compensated by increased insulin secretion. When combined with impaired insulin secretion, insulin resistance plays an important role in type 2 diabetes (1). Insulin-resistance is also associated with a variety of pathological conditions, including trauma, infection, and cancer. Obesity and type 2 diabetes are the most common metabolic diseases in Western societies, together affecting as much as half of the adult population (2). The prevalence of these conditions is not only high, but continues to increase. We have only recently come to appreciate the role of fat, especially visceral fat, as an endocrine organ. Visceral fat is the source of a number of substances which might play a role in the development of insulin resistance. Among the latter are tumor necrosis factor-α (TNF-α), adiponectin, IL-6, resistin and free fatty acids. This review will discuss the regulation of insulin responses by TNF-α and evidence supporting the hypothesis that over expression of TNF-α plays a role in the pathophysiology of insulin resistance.
Similar content being viewed by others
References
Greenberg, A. S. and McDaniel, M. L. (2002). Eur. J. Clin. Invest. 32, 24–34.
Must, A., Spadano, J., Coakley, E. H., Field, A. E., Colditz, G., and Dietz, W. H. (1999). J. Am. Med. Assoc. 282, 1523–1529.
Old, L. J. (1988). Scientific Amer. 258, 59–75.
Beutler, B., Milsark, I. W., and Cerami, A. C. (1985). Science 229, 869–871.
Borjesson, A., Norlin, A., Wang, X., Andersson, R., and Folkesson, H. G. (2000). Am. J. Physiol. 278, L3-L12.
Stack, W. A., Mann, S. D., Roy, A. J., et al. (1997). Lancet 349, 521–524.
Costelli, P., Carbo, N., Tessitore, L., et al. (1993). J. Clin. Invest. 92, 2783–2789.
Cheung, A. T., Ree, D., Kolls, J. K., Fuselier, J., Coy, D. H., and Bryer-Ash, M. (1998). Endocrinology 139, 4928–4935.
Lang, C. H., Dobrescu, C., and Bagby, G. J. (1992). Endocrinology 130, 43–52.
Moller, D. E. (2000). Trends Endocrinol. Metab. 11(6), 212–217.
Peraldi, P. and Spiegelman, B. T. (1998). Mol. Cell Biochem. 182(1–2), 169–175.
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., and Spiegelman, B. M. (1996). Science 271, 665–668.
Paz, K., Heim, R., LeRoith, D., et al. (1997). J. Biol. Chem. 272, 29911–29918.
Del Aguila, L. F., Claffey, K., and Kirwan, J. P. (1999). Am. J. Physiol. 276, E849-E855.
Engelman, J. A., Berg, A. H., Lewis, R. Y., Lisanti, M. P., and Scherer, P. E. (2000). Mol. Endocrinol. 14, 1557–1569.
Ahmad, F. and Goldstein, B. J. (1977). J. Cell Biochem. 64, 117–127.
Ragolia, L. and Begum, N. (1998). Mol. Cell. Biochem. 182, 49–58.
Liu, R. H., Mizuta, M., Kurose, T., and Matsukura, S. (2002). Int. J. Obes. 26, 318–326.
Cohen, P. and Cohen, P. T. (1989). J. Biol. Chem. 264, 21435–21438.
Youngren, J. F., Paik, J., and Barnard, R. J. (2001). J. Appl. Physiol. 91, 2240–2247.
Dohm, G. L., Tapscott, E. B., Porles, W. J., et al. (1988). J. Clin. Invest. 32, 486–494.
Itani, S. I., Pories, W. J., MacDonald, K. G., and Dohm, G. L. (2001). Metabolism 50(5), 553–557.
Itani, S. I., Zhou, Q., Pories, W. J., MacDonald, K. G., and Dohm, G. L. (2000). Diabetes 49(8), 1353–1358.
Kanety, H., Feinstein, R., Papa, M., Hemi, R., and Karasik, A. (1995). J. Biol. Chem. 270(40), 23780–23784.
Font de Mora, J., Porras, A., Ahn, N., and Santos, E. (1997). Mol. Cell. Biol. 17, 6068–6075.
Halse, R., Pearson, S. L., McCormack, J. G., Yeaman, S. J., and Taylor, R. (2001). Diabetes 50, 1102–1109.
Aguirre, V., Uchida, T., Yenush, L., Davis, R., and White, M. F. (2000). J. Biol. Chem. 275(12), 9047–9054.
Chen, G. and Goeddel, D. V. (2002). Science 296, 1634–1635.
Hirosumi, J., Tuncman, G., Chang, L., et al. (2002). Nature 420, 333–336.
Rui, L., Aguirre, V., Kim, J. K., et al. (2001). J. Clin. Invest. 107(2), 181–189.
Hotamisligil, G. S., Shargill, N. S., and Spiegelman, B. M. (1993). Science 259, 87–91.
Hofmann, C., Lorenz, C. K., Braithwaite, S. S., et al. (1994). Endocrinology 134, 264–270.
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., and Spiegelman, B. M. (1995). J. Clin. Invest. 95, 2409–2415.
Xu, H., Uysal, K. T., Becherer, J. D., Arner, P., and Hotamisligil, G. S. (2002). Diabetes 51, 1876–1883.
Hamann, A., Benecke, H., Le Marchand-Brustel, Y., Susulic, V. S., Lowell, B. B., and Flier, J. S. (1995). Diabetes 44, 1266–1273.
Begum, N. and Ragolia, L. (1996). Endocrinology 137, 2441–2446.
Borst, S. E. and Bagby, G. J. (2004). Cytokine (in review).
Morin, C. L., Gayles, E. C., Podolin, D. A., Wei, Y., Xu, M., and Pagliassotti, M. J. (1998). Endocrinology 139, 4998–5005.
Argilés, J. P., Alvarez, B., and López-Soriano, J. (1997). Med. Res. Rev. 17(5), 477–498.
Bulló-Bonet, M., Garcia-Lorda, P., Lopez-Soriano, F. J., Argiles, J. M., and Salas-Salvado, J. (1999). FEBS Lett. 451(3), 215–219.
Bossola, M., Muscaritoli, M., Bellatone, R., et al. (2000). Eur. J. Clin. Invest. 30(12), 1107–1112.
Sharma, R. and Anker, S. D. (2002). Int. J. Cardiol. 85(1), 161–171.
Tsigos, C., Kyrou, I., Chala, E., et al. (1999). Metabolism 48, 1332–1335.
Kern, P. A., Ranganathan, S., Li, C., Wood, L., and Ranganathan, G. (2001). Am. J. Physiol. 280, E745-E751.
Koistinen, H. A., Bastard, J. P., Dusserre, E., et al. (2000). Eur. J. Clin. Invest. 30, 302–310.
Fan, J., Char, D., Bagby, G. J., Gelato, M. C., and Lang, C. H. (1995). Am. J. Physiol. 269, R1204-R1212.
Borst, S. E. and Bagby, G. J. (2002). Metabolism 51, 1061–1064.
Borst, S. E. and Conover, C. F. (2004). Int. J. Obes. (in review).
Saghizadeh, M., Ong, J. M., Garvey, W. T., Henry, R. R., and Kern, P. A. (1996). J. Clin. Invest. 97(4), 1111–1116.
Ventre, J., Doebber, T., Wu, M., et al. (1997). Diabetes 46, 1526–1531.
Hotamisligil, G. S. (1999). Exp. Clin. Endocrinol. Diabetes 107(02), 119–125.
Feldman, M., Taylor, P., Paleolog, F. M., and Miani, R. N. (1998). Transplant. Proc. 30, 4126–4127.
Van Dulleman, H. M., Deventer, S. J., Hommes, D. W., et al. (1995). Gastroenter. 109, 129–135.
Paquot, N., Castillo, M. J., Lefebvre, P. J., and Scheen, A. J. (2000). J. Clin. Endocrinol. Metab. 85, 3316–1319.
Ofei, F., Hurel, S., Newkirk, J., Sopwith, M., and Taylor, R. (1996). Diabetes 45, 881–885.
Steppan, C. M., Bailey, S. T., Bhat, S., et al. (2001). Nature 409, 307–312.
Rajala, M. W., Obici, S., Scherer, P. E., and Rossetti, L. (2003). J. Clin. Invest. 111(2), 225–230.
Hotamisligil, G. S. (2003). J. Clin. Invest. 111(2), 173–174.
Yamauchi, T., Kamon, J., Waki, H., et al. (2001). Nat. Med. 7, 941–946.
Beltowski, J. (2003). Med. Sci. Monit. 9(2), RA55-RA61.
Boden, G. (1996). Diabetes Care 19, 394–395.
Boden, G. (1997). Diabetes 46(1), 3–10.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Borst, S.E. The role of TNF-α in insulin resistance. Endocr 23, 177–182 (2004). https://doi.org/10.1385/ENDO:23:2-3:177
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:23:2-3:177